You're reading the free version. Trader adds the live tape and alerts.
Start tracking
SPRO Award Disclosure
Thomas Frank E · SEC Form 4 · Filed Jun 25, 2026
Award
Calculated transaction value
$0
Thomas Frank E Director
SPRO
Spero Therapeutics
SPRO
Transaction date
Jun 23, 2026
Public filing date
Jun 25, 2026
Filing lag
Filed 2 days later
SPRO daily price context
Close on/before transaction
$2.15
Jun 23, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option (right to buy) on Common Stock
- Quantity / price
- 20,000 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001193125-26-283209
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Spero Therapeutics, Inc. SPRO | Award | Jun 23, 2026 | $0 |
| Spero Therapeutics, Inc. SPRO Current | Award | Jun 23, 2026 | $0 |